Anxiolytic effects of phosphodiesterase-2 inhibitors associated with increased cGMP signaling

Neuroscience

• Anxiety Disorder 16%
• Anxiogenic 33%
• Anxiolytic 16%
• Arginine Methyl Ester 16%
• Aspartic Acid 16%
• Behavior (Neuroscience) 66%
• Benzamide 16%
• Cell Signaling 16%
• Cyclic Adenosine Monophosphate 16%
• Cyclic Guanosine Monophosphate 100%
• Diazepam 16%
• Elevated Plus Maze 33%
• Guanylate Cyclase 33%
• Nitric Oxide Synthase 33%
• Phosphodiesterase 100%
• Primary Culture 16%

Biochemistry, Genetics and Molecular Biology

• Arginine 16%
• Aspartic Acid 16%
• Cyclic Adenosine Monophosphate 16%
• Cyclic Guanosine Monophosphate 100%
• Diazepam 16%
• Guanylate Cyclase 33%
• Hole Board Test 16%
• Immobilization Stress 33%
• Neurochemical 16%
• Nitric Oxide Synthase 33%
• Open Field Test 16%
• Phosphodiesterase 2 100%
• Primary Culture 16%

Pharmacology, Toxicology and Pharmaceutical Science

• 1h 1,2,4 oxadiazolo[4,3 A]quinoxalin 1 One 16%
• Anxiety Disorder 16%
• Anxiolytic 16%
• Arginine Methyl Ester 16%
• Aspartic Acid 16%
• Benzamide 16%
• Cyclic GMP 100%
• Diazepam 16%
• Guanylate Cyclase 16%
• Guanylate Cyclase Inhibitor 16%
• Nitric Oxide Synthase 16%
• Nitric Oxide Synthase Inhibitor 16%
• Phosphodiesterase 100%
• Primary Culture 16%